Skip to main content
. Author manuscript; available in PMC: 2017 Apr 1.
Published in final edited form as: J Acquir Immune Defic Syndr. 2016 Apr 1;71(4):359–366. doi: 10.1097/QAI.0000000000000866

Figure 2.

Figure 2

Levels of inflammatory mediators for all subjects over time with depot-medroxyprogesterone acetate (DMPA)-fitted trend lines pre- and post-DMPA. A: Interleukin (IL)-1 receptor antagonist. B, IL-8. C, secretory leukocyte protease inhibitor (SLPI). D, il-6. E, Interferon-γ-inducible protein 10 (IP-10). P-values and estimates were calculated using linear mixed effects models with linear splines pre- and post-DMPA initiation (random slopes post DMPA-initiation).